Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott Requadt Insider Profile
11 Followers
Scott Requadt, Director at Avrobio, holds 2.96M shares in Avrobio (Ticker: AVRO), holds ― shares in VBI Vaccines (Ticker: VBIV), holds 30.00K shares in ESSA Pharma (Ticker: EPIX).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-34.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Scott Requadt holds in companies
Most Profitable Insider Trade
The most profitable trade made by Scott Requadt
Scott Requadt's Trading History
Avrobio
Jun 25, 2018
Director
Uninformative Buy
―
$3.61M
VBI Vaccines
―
Director
―
―
ESSA Pharma
Jan 16, 2024
Director
Uninformative Sell
―
$206.41K
Tourmaline Bio
Jul 06, 2023
Former Chief Executive Officer
Uninformative Sell
36.30K
$16.29M
List of latest transactions for each holding click on a transaction to see Scott Requadt's performance on stock
You May Also Like
Scott Requadt insider profile FAQ
What is the percentage of profitable transactions made by Scott Requadt?
The percentage of profitable transactions made by Scott Requadt is 0%.
What is the average return per transaction made by Scott Requadt?
The average return per transaction made by Scott Requadt is -34.30%.
What stocks does Scott Requadt hold?
Scott Requadt holds: AVRO, VBIV, EPIX, TRML stocks.
What was Scott Requadt’s latest transaction?
Scott Requadt latest transaction was an Uninformative Buy of ―.
What was Scott Requadt's most profitable transaction?
Scott Requadt’s most profitable transaction was an Informative Buy of TRML stock on July 28, 2022. The return on the trade was -30.80%.
What is Scott Requadt's role in Avrobio?
Scott Requadt's role in Avrobio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.